Cationic solid lipid nanoparticles with primary and quaternary amines for release of saquinavir and biocompatibility with endothelia

Colloids and Surfaces B: Biointerfaces

Volumn 101, Issue , 2013, Pages 101-105

  Kuo, Yung Chih ^a   Wang, Cheng Chin ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Biocompatibility; Cationic solid lipid nanoparticle; Drug release; Endothelium; Saquinavir

Indexed keywords

BIONANOTECHNOLOGY; CONTROLLED RELEASE; DISSOLUTION KINETICS; DISSOLUTION PROFILES; DRUG RELEASE; ENDOTHELIUM; ENTRAPMENT EFFICIENCY; EXTERNAL SURFACES; HUMAN BRAIN-MICROVASCULAR ENDOTHELIAL CELLS; LIPID CORES; QUATERNARY AMINES; SAQUINAVIR; SOLID LIPID NANOPARTICLE (SLN); SUSTAINED RELEASE; WEIGHT PERCENTAGES;

BIOCOMPATIBILITY; DISSOLUTION; DRUG PRODUCTS; ENDOTHELIAL CELLS; NANOPARTICLES;

CHOLESTEROL;

AMINE DEHYDROGENASE; CHOLESTEROL; ESTERQUAT 1; OCTADECYLAMINE; QUATERNARY AMMONIUM DERIVATIVE; SAQUINAVIR; SOLID LIPID NANOPARTICLE; THEOBROMA OIL; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ABSORPTION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HYDROPHOBICITY; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; PROTON TRANSPORT; SOLVENT EXTRACTION; SUPERNATANT; SUSTAINED RELEASE PREPARATION;

AMINES; BIOCOMPATIBLE MATERIALS; BRAIN; CATIONS; CELL SURVIVAL; CHOLESTEROL; DIFFUSION; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIAL CELLS; ENDOTHELIUM; HIV PROTEASE INHIBITORS; HUMANS; INDICATORS AND REAGENTS; KINETICS; LIPIDS; NANOPARTICLES; SAQUINAVIR; SOLVENTS;

EID: 84863750705     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.06.002     Document Type: Article

References (33)

1. Kim H.R., Kim I.K., Bae K.H., Lee S.H., Lee Y., Park T.G. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol. Pharmacol. 2008, 5:622-631.
2. Kuo Y.C., Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 2009, 365:206-213.
3. Kuo Y.C., Chen H.H. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells. J. Drug Target. 2010, 18:447-456.
4. Xiao K., Li Y., Luo J., Lee J.S., Xiao W., Gonik A.M., Agarwal R.G., Lam K.S. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011, 32:3435-3446.
5. Kuo Y.C., Lin P.I., Wang C.C. Targeting nevirapine delivery across human brain microvesscular endothelial cells using transferrin-grafted poly(lactide-co-glycolide) nanoparticles. Nanomedicine 2011, 6:1011-1026.
6. Abraham A.M., Walubo A. The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration. Int. J. Antimicrob. Agents 2005, 25:392-397.
7. DeMuth P., Hurley M., Wu C., Galanie S., Zachariah M.R., DeShong P. Mesoscale porous silica as drug delivery vehicles: synthesis, characterization, and pH-sensitive release profiles. Microporous Mesoporous Mater. 2011, 141:128-134.
8. Yue Z.G., Wei W., Lv P.P., Yue H., Wang L.Y., Su Z.G., Ma G.H. Surface charge affects cellular uptake and intracellular trafficking of chitosan-based nanoparticles. Biomacromolecules 2011, 12:2440-2446.
9. Brayner R. The toxicological impact of nanoparticles. Nanotoday 2008, 3:48-55.
10. Wischke C., Borchert H.H., Zimmermann J., Siebenbrodt I., Lorenzen D.R. Stable cationic microparticles for enhanced model antigen delivery to dendritic cells. J. Control. Release 2006, 114:359-368.
11. Thomas C., Gupta V., Ahsan F. Influence of surface charge of PLGA particles of recombinant hepatitis B surface antigen in enhancing systemic and mucosal immune responses. Int. J. Pharm. 2009, 379:41-50.
12. Howell D.C. Statistical Methods for Psychology 2009, Cengage Learning, Wadsworth, Australia. 7th ed.
13. Quinn G.P., Keough M.J. Experimental Design and Data Analysis for Biologists 2002, Cambridge University Press, New York, NY.
14. Svenson S. Controlling surfactant self-assembly. Curr. Opin. Colloid Interface Sci. 2004, 9:201-212.
15. Asawakarn T., Cladera J., O'Shea P. Effects of the membrane dipole potential on the interaction of saquinavir with pospholipid membranes and plasma membrane receptors of caco-2 cells. J. Biol. Chem. 2001, 42:38457-38463.
16. Martin R.E., Butterworth A.S., Gardiner D.L., Kirk K., McCarthy J.S., Skinner-Adams T.S. Saquinavir inhibits the malaria parasite's chloroquine resistance transporter. Antimicrob. Agents Chemother. 2012, 56:2283-2289.
17. Hasmonay H., Dupeyrat M., Dupeyrat R. Stearate thin films of adjustable refractive index and some practical applications. Opt. Acta (Lond.) 1976, 23:665-677.
18. Wang Y.S., Jiang Q., Li R., Liu L., Zhang Q., Wang Y., Zhao J. Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel. Nanotechnology 2008, 19:145101.
19. Vivek K., Reddy H., Murthy R.S.R. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles. AAPS PharmSciTech 2007, 8:E1-E9.
20. Yuan H., Huang L., Du Y., Ying X., You J., Hu F., Zeng S. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system. Colloids Surf. B 2008, 61:132-137.
21. Mühlen A.Z., Schwarz C., Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery - drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998, 45:149-155.
22. Müller R.H., Mäder K., Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur. J. Pharm. Biopharm. 2000, 50:161-171.
23. Pathak S.M., Musmade P., Dengle S., Karthik A., Bhat K., Udupa N. Enhanced oral absorption of saquinavir with methyl-beta-cyclodextrin - preparation and in vitro and in vivo evaluation. Eur. J. Pharm. Sci. 2010, 41:440-451.
24. Subedi R.K., Kanga K.W., Choi H.K. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur. J. Pharm. Sci. 2009, 37:508-513.
25. Harding C.V., Roof R.W., Allen P.M., Unanue E.R. Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:2740-2744.
26. Mével M., Kamaly N., Carmona S., Oliver M.H., Jorgensen M.R., Crowther C., Salazar F.H., Marion P.L., Fujino M., Natori Y., Thanou M., Arbuthnot P., Yaouanc J.J., Jaffrès P.A., Miller A.D. DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. J. Control. Release 2010, 143:222-232.
27. Tseng L.P., Liang H.J., Liu D.Z. Liposomes incorporated with cholesterol for drug release triggered by magnetic field. J. Med. Biol. Eng. 2007, 27:29-34.
28. Vighi E., Ruozi B., Montanari M., Battini R., Leo E. pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles. Int. J. Pharm. 2010, 15:254-261.
29. Tehrani-Bagha A.R., Oskarsson H., van Ginkel C.G., Holmberg K. Cationic ester-containing gemini surfactants: chemical hydrolysis and biodegradation. J. Colloid Interface Sci. 2007, 312:444-452.
30. Tabbatt K., Sameti M., Olbrich C., Müller R.H., Lehr C.M. Effect of cationic lipid and matrix lipid composition on solid lipid nanoparticle-mediated gene transfer. Eur. J. Pharm. Biopharm. 2004, 57:155-162.
31. Perales S., Alejandre M.J., Palomino-Morales R., Torres C., Iglesias J., Linares A. Effect of oxysterol-induced apoptosis of vascular smooth muscle cells on experimental hypercholesterolemia. J. Biomed. Biotechnol. 2009, 2009:456208.
32. Lizard G., Deckert V., Dubrez L., Moisant M., Gambert P., Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am. J. Pathol. 1996, 148:1625-1638.
33. Zhao Y.F., Wang L., Lee S., Sun Q., Tuo Y., Wang Y., Pei J., Chen C. Cholesterol induces mitochondrial dysfunction and apoptosis in mouse pancreatic beta-cell line MIN6 cells. Endocrine 2010, 37:76-82.